Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XAY.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XAY.1.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.1.55NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.1.55NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.55NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BY.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BY.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BY.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EA.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EA.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EA.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XJNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XJNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XJNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BR.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BR.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BR.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBF.8NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBF.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBF.8NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.1.29NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.1.29NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.1.29NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CM.5.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CM.5.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CM.5.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CM.8.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CM.8.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CM.8.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBSNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBSNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBSNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BN.1.2.8NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BN.1.2.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BN.1.2.8NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XAHNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XAHNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XAHNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.2.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.2.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBJ.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBJ.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBJ.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EP.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EP.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EP.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.4.1.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.4.1.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.4.1.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used